1 陈竺. 全国第三次死因回顾抽样调查报告[M]. 北京:中国协和医科大学出版社, 2008:14-15.2 Zhao D, Liu J, Wang W, et al. Epidemiologicalt ransition of st roke in China:twenty-one-yearobservational study from the Sino-MONICA-BeijingProject[J]. Stroke, 2008, 39:1668-1674.3 路静, 徐玲, 翟屹, 等. 中国1993-2008年脑血管病直接经济负担研究[J ]. 中华流行病学杂志, 2014,35:1263-1266.4 王陇德. 中国脑卒中防治报告2015[M]. 北京:中国协和医科大学出版社, 2015:9-11.5 Hu D, Sun Y. Epidemiology, risk factors for stroke, andmanagement of atrial fibrillation in China[J]. J Am CollCardiol, 2008, 52:865-868.6 Wang Y, Zhao X, Jiang Y, et al. Prevalence, knowledge,and treatment of transient ischemic attacks in China[J].Neurology, 2015, 84:2354-2361.7 Wu Z, Yao C, Zhao D, et al. Sino-MONICA project:acollaborative study on trends and determinants incardiovascular diseases in China, Part i:morbidity andmortality monitoring[J]. Circulation, 2001, 103:462-468.8 国家"十五"攻关冠心病、脑卒中综合危险度评估及干预国人缺血性心血管病发病危险的评估方法及简易评估工具的开发研究[J]. 中华心血管病杂志, 2003,31:893-901.9 王薇, 赵冬, 刘静, 等. 中国35~64岁人群心血管病危险因素与发病危险预测模型的前瞻性研究[J]. 中华心血管病杂志, 2003, 31:902-908.8 陈可冀, 刘玥. 2013年中美国家心血管病报告要点对比解读及其启示[J]. 中国中西医结合杂志, 2013,33:293-297.10 Longde W, Ling Y, Yang H, et al. Fixed-dosecombination treatment after stroke for secondaryprevention in China:a national community-basedstudy[J]. Stroke, 2015, 46:1295-1300.11 吴锡桂, 顾东风, 武阳丰, 等. 首都钢铁公司人群心血管病24年干预效果评价[J]. 中华预防医学杂志, 2003,37:93-97.12 Pan XR, Li GW, Hu YH, et al. Effects of diet andexercise in preventing NIDDM in people withimpaired glucose tolerance. The Da Qing IGT andDiabetes Study[J]. Diabetes Care, 1997, 20:537-544.13 Li G, Zhang P, Wang J, et al. The long-term effect oflifestyle interventions to prevent diabetes in the ChinaDa Qing Diabetes Prevention Study:a 20-year followupstudy[J]. Lancet, 2008, 371:1783-1789.14 Jia Z, Wu S, Zhou Y, et al. Metabolic syndrome and itscomponents as predictors of stroke in middle-aged andelderly Chinese people[J]. Neurol Res, 2011, 33:453-459.15 Zhang Q, Zhou Y, Gao X, et al. Ideal cardiovascularhealth met r ics and the r isks of ischemic andintracerebral hemorrhagic stroke[J]. Stroke, 2013,44:2451-2456.16 Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapyin primary prevention of stroke among adults withhypertension in China:the CSPPT randomized clinicaltrial[J]. JAMA, 2015, 313:1325-1335.17 Feigin VL, Lawes CM, Bennett DA, et al. Worldwidestroke incidence and early case fatality reported in56 population-based studies:a systematic review[J].Lancet Neurol, 2009, 8:355-369.18 Mahmood SS, Levy D, Vasan RS, et al. TheFramingham Heart Study and the epidemiology ofcardiovascular disease:a historical perspective[J].Lancet, 2014, 383:999-1008.19 Pietinen P, Nissinen A, Vartiainen E, et al. Dietarychanges in the North Karelia Project (1972-1982)[J].Prev Med, 1988, 17:183-193.20 Hofman A, Breteler MM, van Duijn CM, et al. TheRotterdam Study:2010 objectives and design update[J].Eur J Epidemiol, 2009, 24:553-572.21 Carandang R, Seshadri S, Beiser A, et al. Trends inincidence, lifetime risk, severity, and 30-day mortalityof stroke over the past 50 years[J]. JAMA, 2006,296:2939-2946.22 Rose G, Khaw KT, Marmot M. ROSE预防医学策略[M]. 吕筠, 李立明, 译. 北京:中国协和医科大学出版社,2009:1-26.23 Di AE, Kaptoge S, Wormser D, et al. Association ofcardiometabolic multimorbidity with mortality[J].JAMA, 2015, 314:52-60.24 O'Donnell MJ, Xavier D, Liu L, et al. Risk factors forischaemic and intracerebral haemorrhagic stroke in 22countries (the INTERSTROKE study):a case-controlstudy[J]. Lancet, 2010, 376:112-123.25 Larsson SC, Akesson A, Wolk A. Primary preventionof stroke by a healthy lifestyle in a high-risk group[J].Neurology, 2015, 84:2224-2228.26 Wang Y, Wang Y, Zhao X, et al. Clopidogrel withaspirin in acute minor stroke or transient ischemicattack[J]. N Engl J Med, 2013, 369:11-19.27 Quinn CC, Shardell MD, Terrin ML, et al. Clusterrandomizedtrial of a mobile phone personalizedbehavioral intervention for blood glucose control[J].Diabetes Care, 2011, 34:1934-1942. |